Advertisement
Advertisement
Advertisement

The Latest

A laboratory technician at the Synthetic Biology and Biosurveillance Branch at the U.S. Army Medical Research Institute of Infectious Diseases demonstrates the Biodefense Mass Sequencing and Surveillance assay, developed by a team of researchers under the direction of branch chief Lt. Col. Jeffrey Kugelman during the coronavirus pandemic as a way to rapidly test large numbers of Service Members for exposure to COVID-19. BMASS can be used to test for multiple diseases at the same time, extending its potential beyond just COVID-19 surveillance. (DOD photo by: Paul Lagasse)

Army turning to AI in its fight against biological threats

Upcoming Events

Advertisement